Trends in Female Contraceptive Industry 2016-2020

Page 1

Global Female Contraceptive Market 2016-2020

Global Female Contraceptive Market 2016-2020 is the latest addition to Sandlerresearch.org industry research reports collection. Adolescent fertility regulation and pregnancy prevention are important healthcare issues today. Although it is difficult to gauge the full extent of the unmet need for contraception, there is a great need for reproductive and sexual health education owing to the rise in STDs. Research suggests that behavior in adolescence results in a pattern for the rest of an individual’s life. The absence of sexual and reproductive healthcare programs for adolescents can result in unwanted pregnancies and unsafe abortions. The analysts forecast Global Female Contraceptive Market to grow at a CAGR of 3.48% during the period 2016-2020. Covered in this Report This report covers the present scenario and the growth prospects of the global Female Contraceptive Market for 2016-2020. Inquire for more information @ http://www.sandlerresearch.org/inquire-beforebuying?rname=62103 Key vendors Allergan Merck Millipore Pfizer Teva Pharmaceuticals Other prominent vendors Afaxys Agile Therapeutics Ansell Bayer Pharma Caya Ferring Pharmaceuticals Female Health Fuji Latex HLL Lifecare


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.